Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chemistry Analyzer Offers Fully Automatic Biochemistry and Turbidimetric Analysis

By LabMedica International staff writers
Posted on 09 Jun 2010
A new chemistry analyzer that is cost-effective for lower-throughput labs offers fully automatic biochemistry and turbidimetric analysis.

ChemWell-T is a PC-controlled, random access open chemistry analyzer system. More...
It includes powerful, easy-to-use software for programming and running assays, panels, and indices with high-level options such as customer design reports, patient database, and complete quality control (QC) package.

The instrumentation company, Awareness Technology Inc. (Palm City, FL, USA), has added the ChemWell-T to its biochemistry line. The company offers a full line of Stat Fax chemistry analyzers, enzyme immuno assay (EIA) plate and strip readers, plate washers, ChemWell automatic EIA and chemistry analyzers, ChroMate plate readers, and LumiStat Luminometers--all priced competitively in the global market.

ChemWell analyzers are available worldwide only through authorized, factory trained distributors. The software includes English, Spanish, Portuguese, and Russian languages.

The engineers at Awareness Technology design instruments with an emphasis on cost control. Low transfer prices are achieved by employing an extensive body of existing technology, adaptable hardware, and software tools. Low-cost solutions are always investigated first. The features that enable cost control are durability that reduces expensive down time and repair costs; ease of use that saves money in training and in repeated work; and convenience features that save labor time.

Awareness Technology, Inc. is known worldwide as a leader in clinical laboratory instrumentation for small- to medium-sized labs.

Related Links:

Awareness Technology




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.